Akero Therapeutics share price today

(AKRO)

Akero Therapeutics share price is $28.89 & ₹2,463.45 as on 27 Dec 2024, 2.30 'hrs' IST

$28.89

▲

0.33

(1.16%)

Market is closed - opens 8 PM, 27 Dec 2024

View live Akero Therapeutics share price in Dollar and Rupees. Guide to invest in Akero Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Akero Therapeutics. Get details on the Indian mutual funds that are investing in Akero Therapeutics. Get Analyst recommendations and forecasts along with all the Akero Therapeutics's financials.

Akero Therapeutics share price movements

Today's Low: $28.02
Today's High: $29.04
$28.89
3.01%
Downside
Day's Volatility :3.5%
Upside
0.51%
52 Weeks Low: $15.32
52 Weeks High: $37.00
$28.89
46.97%
Downside
52 Weeks Volatility :58.59%
Upside
21.92%

Akero Therapeutics Returns

Period	Akero Therapeutics Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	1.13%	-9.0%	0.0%
6 Months	21.74%	-4.6%	0.0%
1 Year	18.9%	3.0%	0.0%
3 Years	34.78%	0.0%	-21.1%

Akero Therapeutics Key Statistics

in dollars & INR

Previous Close	$28.56
Open	$28.13
Today's High	$29.0375
Today's Low	$28.02
Market Capitalization	$2.0B
Today's Volume	$265.9K
52 Week High	$37.0
52 Week Low	$15.32
Revenue TTM	$0.0
EBITDA	$-269.3M
Earnings Per Share (EPS)	$-3.78
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-35.9%

How to invest in Akero Therapeutics from India?

It is very easy for Indian residents to invest directly in Akero Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Akero Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Akero Therapeutics or AKRO on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Akero Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Akero Therapeutics shares which would translate to 0.030 fractional shares of Akero Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Akero Therapeutics, in just a few clicks!

Returns in Akero Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

Akero Therapeutics investment value today

Current value as on today

₹1,22,600

Returns

₹22,600

(+22.6%)

Returns from Akero Therapeutics Stock

₹20,275 (+20.27%)

Dollar Returns

₹2,325 (+2.33%)

Indian investors sentiment towards Akero Therapeutics

30%

Period: Sep 27, 2024 to Dec 26, 2024. Change in 30 Days versus previous period

Search volume for Akero Therapeutics on INDmoney from India has grown in the last 30 days as on Dec 27, 2024. 30% more investors are searching Akero Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Akero Therapeutics

Wellington Management Company LLP
11.31%
HHG PLC
10.14%
RTW INVESTMENTS, LLC
8.48%
BlackRock Inc
8.00%
General Atlantic Llc
7.50%
T. Rowe Price Associates, Inc.
5.46%

Analyst Recommendation on Akero Therapeutics

Buy

87%Buy

12%Hold

0%Sell

Based on 16 Wall street analysts offering stock ratings for Akero Therapeutics(by analysts ranked 0 to 5 stars)

Based on 16 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Akero Therapeutics

What analysts predicted

Upside of 67.09%

Current:

$28.89

Target:

$48.27

Insights on Akero Therapeutics

Price Movement
In the last 3 years, AKRO stock has moved up by 30.1%
AKRO vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.2% return, outperforming this stock by 6.8%

Akero Therapeutics Technicals Summary

Sell

Neutral

Buy

Akero Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Akero Therapeutics Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Akero Therapeutics Inc	-11.22%	21.74%	18.9%	34.78%	4.73%
Regeneron Pharmaceuticals, Inc.	-5.12%	-32.02%	-18.97%	11.91%	91.19%
Biontech Se	-3.72%	42.02%	7.95%	-52.72%	226.93%
Alnylam Pharmaceuticals, Inc.	-3.99%	0.1%	24.29%	44.19%	112.09%
Vertex Pharmaceuticals Incorporated	-12.61%	-12.92%	-0.27%	83.92%	86.41%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Akero Therapeutics Inc	NA	NA	NA	-3.97	-0.36	-0.23	NA	10.61
Regeneron Pharmaceuticals, Inc.	17.67	17.67	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.06	0.51	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Akero Therapeutics Inc	Buy	$2.0B	4.73%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$78.5B	91.19%	17.67	33.61%
Biontech Se	Buy	$27.4B	226.93%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$31.4B	112.09%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$105.1B	86.41%	32.84	-4.51%

About Akero Therapeutics

akero therapeutics is developing best-in-class medicines that restore metabolic balance to treat non-alcoholic steatohepatitis (nash) and other serious metabolic diseases. akero's lead clinical program, akr-001, is a long-acting fc fusion modified fgf21 protein and potential best-in-class treatment for nash. akr-001 builds upon two decades of work on fgf21 biology. it is designed to affect both the liver and adipose tissue, reducing liver fat and suppressing inflammation and fibrosis.

Organization	Akero Therapeutics
Employees	60
CEO	Dr. Andrew Cheng M.D., Ph.D.
Industry	Health Technology

Management People of Akero Therapeutics

Name	Title
Dr. Andrew Cheng M.D., Ph.D.	President, CEO & Director
Dr. Jonathan M. Young J.D., Ph.D.	Co-Founder, Executive VP, COO & Secretary
Dr. Timothy Rolph Ph.D.	Co-Founder & Chief Scientific Officer
Mr. William R. White J.D.	Executive VP, CFO, Treasurer & Head of Corporate Development
Ms. Catriona Yale	Executive VP & Chief Development Officer
Mr. Scott A. Gangloff	Chief Technical Officer
Mr. John J. Schembri	Senior VP & Head of Finance
Mr. Patrick Lamy	Senior Vice President of Commercial Strategy

Important FAQs about investing in Akero Therapeutics from India :

What is Akero Therapeutics share price today?

Akero Therapeutics share price today stands at $28.89, Open: $28.13 ; Previous Close: $28.56 ; High: $29.04 ; Low: $28.02 ; 52 Week High: $37.00 ; 52 Week Low: $15.32. The stock opens at $28.13, after a previous close of $28.56. The stock reached a daily high of $29.04 and a low of $28.02, with a 52-week high of $37.00 and a 52-week low of $15.32.

Can Indians buy Akero Therapeutics shares?

Yes, Indians can invest in the Akero Therapeutics (AKRO) from India.

With INDmoney, you can buy Akero Therapeutics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Akero Therapeutics at zero transaction cost.

How can I buy Akero Therapeutics shares from India?

It is very easy to buy Akero Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Akero Therapeutics be purchased?

Yes, you can buy fractional shares of Akero Therapeutics with INDmoney app.

What are the documents required to start investing in Akero Therapeutics stocks?

To start investing in Akero Therapeutics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.